-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NgV1Wogo5fmtCzghey858nNIXs7ute4erCYWoJfgy/TLE71wE+FVf+XPCs7ozGsD ej9xyrOdR4EwcBBJFJMrXQ== 0001264908-10-000001.txt : 20100301 0001264908-10-000001.hdr.sgml : 20100301 20100301161702 ACCESSION NUMBER: 0001264908-10-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100225 FILED AS OF DATE: 20100301 DATE AS OF CHANGE: 20100301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANGE DAVID L CENTRAL INDEX KEY: 0001264908 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 10644703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-02-25 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001264908 GRANGE DAVID L 929 NORTH FRONT STREET WILMINGTON NC 28401 1 1 0 0 Chief Executive Officer Common Stock 61045 D Stock Options (to buy) 21.17 2010-02-25 4 A 0 100000 0 A 2011-02-25 2020-02-25 Common Stock 100000 100000 D Stock Options (to buy) 22.75 2010-07-01 2019-07-01 Common Stock 200000 200000 D Stock Options (to buy) 42.77 2008-05-21 2018-05-20 Common Stock 6265 6265 D 50,000 shares of restricted stock were granted upon the Reporting Person's acceptance of employment as Chief Executive Officer. These shares vest in four equal increments on 7/1/10, 7/1/11, 7/1/12 and 7/1/13. The options vest in three equal installments on 2/25/11, 2/25/12 and 2/25/13. The options vest in four equal installments of 50,000 on 7/1/10, 7/1/11, 7/1/12 and 7/1/13. Lisa C. Noecker attorney-in-fact for David L. Grange 2010-03-01 -----END PRIVACY-ENHANCED MESSAGE-----